# Interleukin-6 and Thyroid Dysfunction in Hemodialysis Patients

> **NCT07328113** · — · COMPLETED · sponsor: **Dr. Soetomo General Hospital** · enrollment: 65 (actual)

## Conditions studied

- Chronic Kidney Disease on Hemodialysis
- Thyroid Gland Disease

## Interventions

- **DIAGNOSTIC_TEST:** Thyroid hormone

## Key facts

- **NCT ID:** NCT07328113
- **Lead sponsor:** Dr. Soetomo General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-14
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07328113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07328113, "Interleukin-6 and Thyroid Dysfunction in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07328113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*